DOCK8-related Immunodeficiency Syndrome (DIDS): Report of Novel Mutations in Iranian Patients.


Journal

Journal of molecular neuroscience : MN
ISSN: 1559-1166
Titre abrégé: J Mol Neurosci
Pays: United States
ID NLM: 9002991

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 23 03 2021
accepted: 12 04 2021
pubmed: 6 5 2021
medline: 3 3 2022
entrez: 5 5 2021
Statut: ppublish

Résumé

DOCK8 immunodeficiency syndrome (DIDS) is a rare autosomal recessive (AR) disorder characterized by elevated serum IgE levels, eosinophilia, recurrent cutaneous infections, severe eczema, and sinopulmonary and gastrointestinal infections. This syndrome is a multisystem disease that is associated with both immune deficiency and neurological complications. In this study, we describe the clinical characteristics of two Iranian patients with DOCK8 deficiency and propose possible mechanisms for this condition. By using whole exome sequencing (WES), we identified two novel mutations, namely c.3233_3234del AG (p.Q1078fs) in exon 6 and a large deletion with 94 kb (c.405-3231 deletion, p.K135fs), in these two patients. These variations are confirmed with Sanger sequencing and CGH array. Subsequent co-segregation analysis is performed to identify inheritance patterns. Both patients were homozygote and their parents were heterozygote for the variations. For further investigation, prediction tools were applied to identify the pathogenicity of the variations and also for modeling the truncated proteins. The patients did not show neurological abnormalities associated with a deficiency of the N terminal region of DOCK8. The absence of neurological complications in the first patient is justifiable due to the maintenance of the proline-rich region in DOCK8, but for the second patient with expanded deletion which is almost like null DOCK8 protein, it is not presumable, pointing to the fact that the C terminal region of the protein might have functions in the proliferation and migration neurons in the peripheral nervous system. Alternatively, it is possible that neurological abnormalities follow an age-dependent pattern, leading to the appearance of related symptoms later in life. Further multiple functional studies are needed to model different identified variants in animal models to confirm our results and suggest possible mechanisms associated with DOCK8 deficiency in this study.

Identifiants

pubmed: 33948880
doi: 10.1007/s12031-021-01843-5
pii: 10.1007/s12031-021-01843-5
doi:

Substances chimiques

DOCK8 protein, human 0
Guanine Nucleotide Exchange Factors 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2456-2461

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Biggs CM, Keles S, Chatila TA (2017) DOCK8 deficiency: Insights into pathophysiology, clinical features and management. Clin Immunol (Orlando, Fla.) 181:75–82
Bokoch GM (2005) Regulation of innate immunity by Rho GTPases. Trends Cell Biol 15:163–171
doi: 10.1016/j.tcb.2005.01.002
Côté J-F, Motoyama AB, Bush JA, Vuori K (2005) A novel and evolutionarily conserved PtdIns (3, 4, 5) P 3-binding domain is necessary for DOCK180 signalling. Nat Cell Biol 7:797–807
doi: 10.1038/ncb1280
Engelhardt KR, Mcghee S, Winkler S, Sassi A, Woellner C, Lopez-Herrera G, Chen A, Kim HS, Lloret MG, Schulze I (2009) Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol 124(1289–1302):e4
Etienne-Manneville S, Hall A (2002) Rho GTPases in cell biology. Nature 420:629–635
doi: 10.1038/nature01148
Gallo V, Dotta L, Giardino G, Cirillo E, Lougaris V, D’assante R, Prandini A, Consolini R, Farrow EG, Thiffault I (2016) Diagnostics of primary immunodeficiencies through next-generation sequencing. Front Immunol 7:466
Gomes ER, Jani S, Gundersen GG (2005) Nuclear movement regulated by Cdc42, MRCK, myosin, and actin flow establishes MTOC polarization in migrating cells. Cell 121:451–463
doi: 10.1016/j.cell.2005.02.022
Griggs BL, Ladd S, Saul RA, Dupont BR, Srivastava AK (2008) Dedicator of cytokinesis 8 is disrupted in two patients with mental retardation and developmental disabilities. Genomics 91:195–202
doi: 10.1016/j.ygeno.2007.10.011
Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, Miller JA, O’connell AC, Puck JM (1999) Hyper-IgE syndrome with recurrent infections—an autosomal dominant multisystem disorder. N Engl J Med 340:692–702
doi: 10.1056/NEJM199903043400904
Hagl B, Spielberger BD, Thoene S, Bonnal S, Mertes C, Winter C, Nijman IJ, Verduin S, Eberherr AC, Puel A (2018) Somatic alterations compromised molecular diagnosis of DOCK8 hyper-IgE syndrome caused by a novel intronic splice site mutation. Sci Rep 8:1–10
doi: 10.1038/s41598-018-34953-z
Ham H, Guerrier S, Kim J, Schoon RA, Anderson EL, Hamann MJ, Lou Z, Billadeau DD (2013) Dedicator of cytokinesis 8 interacts with talin and Wiskott-Aldrich syndrome protein to regulate NK cell cytotoxicity. J Immunol 190:3661–3669
doi: 10.4049/jimmunol.1202792
Kienzler A-K, Van Schouwenburg PA, Taylor J, Marwah I, Sharma RU, Noakes C, Thomson K, Sadler R, Segal S, Ferry B (2016) Hypomorphic function and somatic reversion of DOCK8 cause combined immunodeficiency without hyper-IgE. Clin Immunol 163:17–21
doi: 10.1016/j.clim.2015.12.003
Lämmermann T, Renkawitz J, Wu X, Hirsch K, Brakebusch C, Sixt M (2009) Cdc42-dependent leading edge coordination is essential for interstitial dendritic cell migration. Blood J Am Soc Hematol 113:5703–5710
Meller N, Irani-Tehrani M, Kiosses WB, Del Pozo MA, Schwartz MA (2002) Zizimin1, a novel Cdc42 activator, reveals a new GEF domain for Rho proteins. Nat Cell Biol 4:639–647
doi: 10.1038/ncb835
Miyamoto Y, Torii T, Kawahara K, Tanoue A, Yamauchi J (2016) Dock8 interacts with Nck1 in mediating Schwann cell precursor migration. Biochem Biophys Rep 6:113–123
pubmed: 28955869 pmcid: 5600352
Nishikimi A, Kukimoto-Niino M, Yokoyama S, Fukui Y (2013) Immune regulatory functions of DOCK family proteins in health and disease. Exp Cell Res 319:2343–2349
doi: 10.1016/j.yexcr.2013.07.024
Ruiz-García R, Lermo-Rojo S, Martínez-Lostao L, Mancebo E, Mora-Díaz S, Paz-Artal E, Ruiz-Contreras J, Anel A, González-Granado LI, Allende LM (2014) A case of partial dedicator of cytokinesis 8 deficiency with altered effector phenotype and impaired CD8+ and natural killer cell cytotoxicity. J Allergy Clin Immunol 134(218–221):e7
Saghafi S, Pourpak Z, Glocker C, Nussbaumer F, Babamahmoodi A, Grimbacher B, Moin M (2015) The diagnosis of hyper immunoglobulin e syndrome based on project management. Iran J Allergy, Asthma Immunol 126–132
Saghafi S, Pourpak Z, Nussbaumer F, Fazlollahi MR, Houshmand M, Hamidieh AA, Bemanian MH, Nabavi M, Parvaneh N, Grimbacher B (2016) DOCK8 deficiency in six Iranian patients. Clin Case Rep 4:593
doi: 10.1002/ccr3.574
Sassi A, Lazaroski S, Wu G, Haslam SM, Fliegauf M, Mellouli F, Patiroglu T, Unal E, Ozdemir MA, Jouhadi Z (2014) Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels. J Allergy Clin Immunol 133(1410–1419):e13
Shi L (2013) Dock protein family in brain development and neurological disease. Commun Integr Biol 6:e26839
doi: 10.4161/cib.26839
Shiraishi A, Uruno T, Sanematsu F, Ushijima M, Sakata D, Hara T, Fukui Y (2017) DOCK8 protein regulates macrophage migration through Cdc42 protein activation and LRAP35a protein interaction. J Biol Chem 292:2191–2202
doi: 10.1074/jbc.M116.736306
Su HC, Jing H, Angelus P, Freeman AF (2019) Insights into immunity from clinical and basic science studies of DOCK 8 immunodeficiency syndrome. Immunol Rev 287:9–19
doi: 10.1111/imr.12723
Tan I, Yong J, Dong JM, Lim L, Leung T (2008) A tripartite complex containing MRCK modulates lamellar actomyosin retrograde flow. Cell 135:123–136
doi: 10.1016/j.cell.2008.09.018
Tybulewicz VL, Henderson RB (2009) Rho family GTPases and their regulators in lymphocytes. Nat Rev Immunol 9:630–644
doi: 10.1038/nri2606
Vinci G, Chantot-Bastaraud S, El Houate B, Lortat-Jacob S, Brauner R, Mcelreavey K (2007) Association of deletion 9p, 46, XY gonadal dysgenesis and autistic spectrum disorder. Mol Hum Reprod 13:685–689
doi: 10.1093/molehr/gam045
Yang J, Zhang Z, Roe SM, Marshall CJ, Barford D (2009) Activation of Rho GTPases by DOCK exchange factors is mediated by a nucleotide sensor. Science 325:1398–1402
doi: 10.1126/science.1174468
Zhang Q, Davis JC, Lamborn IT, Freeman AF, Jing H, Favreau AJ, Matthews HF, Davis J, Turner ML, Uzel G (2009) Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med 361:2046–2055
doi: 10.1056/NEJMoa0905506

Auteurs

Sahar Yousefnezhad (S)

Department of Molecular Genetics, Rabe Rashidi Institute, Tabriz, Iran.

Jalal Gharesouran (J)

Molecular Genetics Division, GMG center, Tabriz, Iran.
Division of Medical Genetics, Tabriz Children's Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.

Soudeh Ghafouri-Fard (S)

Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Hassan Hosseinzadeh (H)

Molecular Genetics Division, GMG center, Tabriz, Iran.
Department of Allergy and Clinical Immunology, Tabriz Children's Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.

Javad Ahmadian-Heris (J)

Division of Medical Genetics, Tabriz Children's Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.

Amir Hossein Jafari-Rouhi (AH)

Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Mohammad Taheri (M)

Skull Base Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Mohammad_823@yahoo.com.

Maryam Rezazadeh (M)

Division of Medical Genetics, Tabriz Children's Hospital, Tabriz University of Medical Sciences, Tabriz, Iran. Rezazadehm@tbzmed.ac.ir.
Department of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Rezazadehm@tbzmed.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH